Cingulate (CING) - Company Sales Revenue

Corporate emblem and logo of Cingulate Inc (CING)

Cingulate Inc. automates the production of psychotropic agents using multi-layer CNC presses, eliminating human error. The company's sales profile demonstrates cash flow dynamics, with the parameter stabilizing at 0.00. Demand for ADHD therapy remains inflation-independent, while the young executive team is currently optimizing internal processes following a capital restructuring.

CING cingulate.com: Revenue and Sales Volume in the range 07/04/2022 - 11/13/2026

Analytical breakdowns for Cingulate Inc.

- stock value and consensus price forecast:
Stock Quotes Cingulate Corp|CING - Analyst Consensus Forecast
- market capitalization indicators:
Market Value Cingulate Inc.|CING - Total Company Value
- balance sheet net asset value indicators:
Net Asset Value per Share Cingulate|CING - Book Capitalization|Market Cap to Net Assets Ratio cingulate.com|CING - Company Total Assets
- company liabilities and liquidity data:
Total Debt to Capital Coefficient Cingulate Inc.|CING - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio Cingulate Corp|CING - Company Aggregate Debts|Debt to Net Assets Cingulate Inc.|CING - Company Long-Term Liabilities|Company Short-Term Debts Cingulate|Quick Liquidity cingulate.com
- business earnings and investment ratios data:
CING - Net Profit|Projected Future Earnings Cingulate Inc.|CING - Price to Earnings Ratio|Market Cap to Future Earnings Ratio Cingulate Corp|CING - PEG Multiple|Company Value to EBITDA Cingulate Inc.|CING - Operating profit before deduction of amortization|Earnings per share for the trailing year Cingulate|CING - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months cingulate.com|CING - Earnings per share growth in current year|Projected earnings per share growth rate for next year Cingulate Inc.
- company sales and revenue statistics:
CING - Revenue and Sales Volume|Company Future Sales Volume Cingulate Corp|CING - Market Cap to Revenue|Market Cap to Expected Sales Ratio Cingulate Inc.
Summary company analysis:CING - cingulate.com
Manufactured product of cingulate.com

Cingulate Inc. sales reflect the total revenue generated from the sale of goods and services over a fixed period. In fundamental analysis, this metric measures the actual scale of the business and the stability of incoming cash flows. The current sales profile for Cingulate Inc. on the GURU.Markets platform recorded a value of 0.00, confirming the issuer's market position. For Cingulate Inc., the stability of this indicator is bolstered by patent protection for drug delivery systems, ensuring high margins and long-term capitalization.

Competing companies

Company Sales Alkermes Corp (ALKS)|Revenue and Sales Volume AVDL|ATAI (atai.life) - Company Sales Revenue|Company Revenue GH Research GHRS|Mind Medicine (MindMed) Inc. (MNMD) - Company Total Revenue|Compass Pathways - Revenue and Sales Volume|LB Corp (LBRX) - Company Sales|DRUG: Revenue and Sales Volume|VNDA - Company Gross Revenue|Company Revenue Cybin Inc|Company Sales Volume ANRO (Alto Neuroscience Inc)|Revenue and Sales Volume NRXP|silopharma.com (SILO) - Company Total Sales Volume|China Pharma Holdings, Inc. - Company Sales|Revenue and Sales Volume Clearmind Medicine, Inc. CMND|PBM - Company Revenue|SPRC: Company Revenue|SEEL: Revenue and Sales Volume|Virpax Pharmaceuticals, Inc. (VRPX) - Revenue and Sales Volume|Company Sales KRTX